IRCT2013102015076N1已完成早期 1 期
Effecttive Desensitization to wheat, for Allergy with Wheat in 2-18 years old cases for 1 year in Allergy and Immunology clinic in Rasul Akram hospital
试验速览
- 阶段
- 早期 1 期
- 状态
- 已完成
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 years 至 18 years（—）
- 性别
- All
入选标准
- •patients with type1 allergic reaction to wheat flour; age between 2-18 years old; normal physical examination; no sever asthma; no cardiac diseas, no other chronic diseases and informed consent was taken from patients.
- •Exclusion criteria: 1-patients who did not permit us to enter them in the study. 2-patients with hypersensitivity reactions other than type one reaction. 3-patients having cardiac diseases (heart failure, heart valve insufficiency, severe valve stenosis, myocardial infarction) 4- patients with severe pulmonary diseases (severe asthma, chronic obstructive pulmonary disease, severe chronic bronchiolitis). 5-patients age less than 2 or more than 18 years old.
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Rush oral immunotherapy of wheat allergywheat allergyJPRN-UMIN000016051osaka prefectural hospitalmedical center for respiratory and allergic diseases50
已完成
不适用
Desensitization to wheatIRCT20181220042066N1Tehran University of Medical Sciences12
已完成
不适用
Oral Desensitization to Wheat in School Aged ChildrenWheat AllergyNCT01755884Helsinki University Central Hospital100
进行中（未招募）
1 期
Peanut Allergy StudyPeanut AllergyEUCTR2021-002533-42-Outside-EU/EEAAimmune Therapeutics, Inc.
进行中（未招募）
1 期
Treatment of severe peanut allergy with oral immunotherapy with peanuts during protection with anti-IgE antibodies, Xolair (omalizumab).EUCTR2012-005625-78-SEKarolinska Institutet23